Previous Close |
---|
1,400.50p |
5 Day |
|
1 Month |
|
3 Month |
|
YTD |
|
1 Year |
|
Smith & Nephew falls 5.6% after cut in 2018 outlook
Smith & Nephew Supports AAFAO Courses with Donation of More Than $3M of Equipment to The Podiatry Institute
New Q-FIX™ CURVED, Q-FIX MINI and SUTUREFIX CURVED All-Suture Anchor Systems help surgeons access challenging pathology while improving the quality of shoulder and hip repairs
Smith & Nephew announces full commercial release of JOURNEY™ II XR Total Knee Arthroplasty
Smith & Nephew: RCT demonstrates a 71% reduction in the onset of sacral pressure ulcers when adding ALLEVYN�-S LIFE to standard preventative protocol
Smith & Nephew Plc engages in the development, manufacture, marketing, and sale of medical devices. It offers the following products and services: sports medicine joint repair; arthroscopic enabling technologies; trauma and extremities; other surgical businesses; knee and hip implants, and advanced wound care, wound bioactives, and wound devices. It operates through the United Kingdom, United States of America, and Other geographical segments. The company was founded by Thomas James Smith in 1856 and is headquartered in London, the United Kingdom. (See Full Profile)
Name | Chg % | Market Cap |
---|---|---|
aap Implantate AG | €51.13M | |
AorTech International PLC | £2.11M |